We tested the applicability of LInDA to induce AJs formation also in epithelial cancer cells (MDA-MB-468 derived from human breast carcinoma) which do not express α-catenin but still present normal endogenous expression of E-cadherin and β-catenin. The gene discussed is CDH1; the disease is breast carcinoma.